GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Diamond Biofund Inc (TPE:6901) » Definitions » Accounts Payable

Diamond Biofund (TPE:6901) Accounts Payable : NT$0.00 Mil (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Diamond Biofund Accounts Payable?

Diamond Biofund's Accounts Payable for the quarter that ended in Sep. 2024 was NT$0.00 Mil.


Diamond Biofund Accounts Payable Historical Data

The historical data trend for Diamond Biofund's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diamond Biofund Accounts Payable Chart

Diamond Biofund Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Accounts Payable
- - - -

Diamond Biofund Quarterly Data
Dec19 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24 Jun24 Sep24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Diamond Biofund Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


Diamond Biofund Accounts Payable Related Terms

Thank you for viewing the detailed overview of Diamond Biofund's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Diamond Biofund Business Description

Traded in Other Exchanges
N/A
Address
No. 236, Section 4, Xinyi Road,, 11th Floor, Daan District, Taipei City, TWN, 106047
Diamond Biofund Inc is a sustainable biotech venture capital that focuses on the field of biotechnology and medical investment, targeting global and internationally competitive investment targets, including new drug research and development, high-end medical equipment, innovative medical service technology, medical access, agricultural biotechnology.

Diamond Biofund Headlines

No Headlines